한국어
Quantus

Gemvaxlink

064800 · KOSDAQ
₩2,555-1.73%
2026-09-04 close

Gemvaxlink last closed at ₩2,555 (-1.73%) on 2026-09-04. Listed on KOSDAQ; price, financials and dividends update daily after market close.

Loading chart…
Close
No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
303 picks
Next-day win rate
50.7%
Avg next-day
-0.11%
vs market
-0.49%p

Every new-high-plus-volume pick we actually published (Korea market) — not this stock alone.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

D
Overall: 화장품,의류,완구 123/152 · top 81%
Factor composite · relative position in sector

PER — · PBR 0.33 — own-history percentile 0/100 · 100/100

Open self-history band
PER0/100
PBR100/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2024
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 6.13
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
6.13
Beneish M-Score
-2.33

No statistical flag

Sloan accrual
-13.83%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

4/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score4/9

Profitability

  • Positive ROANot passed
  • Positive OCFNot passed
  • Improving ΔROANot passed
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtPass
  • Higher current ratioPass
  • No new sharesPass

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Revenue qualityWarning

매출채권 증가율이 매출 증가율의 1.5배 초과 (3기 연속) — 매출 인식 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Margin trendWarning

영업이익률 악화 (-15.4% → -72.1%, -56.7%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

KRAs of 2026-09-05

화장품,의류,완구

This stock is in 화장품,의류,완구: revenue rank 111 of 148, share 0.1%.

111 / 1480.1%revenue share

Who dominates this industry?

  1. 1효성티앤씨8.3%
  2. 2LG생활건강7.3%
  3. 3코웨이4.6%
  4. 4영원무역홀딩스4.6%
  5. 5미스토홀딩스4.6%
  6. 6포니링크0.1%

Concentration

DistributedCR3 20.3%
HHI 317148 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

MixedDivergent lenses

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
1.85
Direction
확대
Level
좁음
Years
8

Value lens

P90/P10
8.3
Median P/B
0.82
Level
넓음
n
135

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
-72.1%
Interest coverage
-25.9x
Return on equity (ROE)
-19.4%

Operating margin −5pp

Operating loss
Interest coverageBase -25.9x adverse case -27.7x
Return on equity (ROE)Base -19.4% adverse case -24.7%

Revenue −15%

Interest coverage risk
Interest coverageBase -25.9x adverse case -22x
Return on equity (ROE)Base -19.4% adverse case -19.8%

Interest rate +2pp

Interest coverage risk
Interest coverageBase -25.9x adverse case -16.5x
Return on equity (ROE)Base -19.4% adverse case -23.6%

Interest coverage limit

Already below the limit by 74.9pp

Interest coverage limit at an operating margin of 2.8%

Interest expense coverage threshold

Key suppliers · Annual report

Annual reportDART · 2026-03-18

Suppliers disclosed by the company in its 2026-03-18 annual report.

Suppliers without disclosed amount

SMSCLMSCSERVERWAPMMSC

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.

5%+ major-holding disclosures

  • 젬백스25.50%2026-06-22 · 증감 +1.14%p

Other stocks held by the same investors

A filing-based shared-holder record, not investment advice.

Connections

AI-extracted related companies · for reference

Customers
포니 AI현대자동차기아Price comovement r=0.03 (1 year)
Competitors
오토노머스에이투지모셔널웨이모테슬라
🔗 See in the full market map →

Recent filings

Gemvaxlink's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

About Gemvaxlink
What technical signals does Gemvaxlink (064800) have?
Gemvaxlink current technical signals: no active technical signal.
Is Gemvaxlink a cup-and-handle pattern?
No. Gemvaxlink has no valid cup-and-handle signal right now.
What are Gemvaxlink's financials and valuation?
Gemvaxlink's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy